NCT02582671View on ClinicalTrials.gov

The Effectiveness of ABT-450/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C -An Observational Study in Ireland

CompletedOBSERVATIONAL
Enrollment

101

Participants

Timeline

Start Date

November 5, 2015

Primary Completion Date

November 29, 2017

Study Completion Date

November 29, 2017

Conditions
Chronic Hepatitis C
Interventions
DRUG

Ombitasvir/paritaprevir/ritonavir

Co-formulated tablet

DRUG

Dasabuvir

Tablet

DRUG

Ribavirin

Tablet

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY